Behavioral Innovations publishes ABA outcomes data from 1,141 children

By AI, Created 5:31 PM UTC, May 18, 2026, /AGP/ – Behavioral Innovations released a white paper on May 12, 2026, showing measurable gains for 1,141 children receiving ABA therapy across communication, socialization and daily living skills. The Dallas-based provider says children who started by age 2 saw the largest average gains, as the ABA field faces growing pressure for more standardized outcome reporting.

Why it matters: - Behavioral Innovations is publishing standardized outcome data at a time when ABA therapy providers face growing scrutiny from regulators, payors and consumer advocates. - The white paper adds scale to a debate over whether autism therapy providers should show consistent, measurable results across patients and time. - Behavioral Innovations is one of the few large ABA organizations publicly sharing standardized outcomes data at this level.

What happened: - Behavioral Innovations published a white paper on May 12, 2026, based on a retrospective outcomes study of 1,141 children receiving ABA therapy at the company’s centers. - The study used the Vineland-3 Adaptive Behavior Scales, a nationally recognized standardized assessment used in clinical research and developmental evaluation. - The analysis found measurable progress within six months of consistent therapy, with continued gains at 12 months. - The company is based in Dallas and provides center-based ABA therapy for children with autism across multiple states.

The details: - The study found gains across every age group and every level of support needs. - Children who began therapy at age 2 showed the largest average gains of any age group. - Children with moderate-to-higher support needs also showed consistent improvement across all three measured domains. - The measured domains were communication, socialization and daily living skills. - Communication gains included expressing needs and understanding language. - Socialization gains included play, peer engagement and turn-taking. - Daily living skills gains included dressing, eating and following routines independently. - The Vineland-3 is widely regarded as a gold standard for measuring adaptive behavior and the everyday skills children use at home, in school and in the community. - Behavioral Innovations said the study reflects a broader commitment to publishing measurable outcomes and advancing accountability in ABA care. - The company has more than 120 locations across Texas, Oklahoma, Colorado, Maryland, North Carolina and Virginia. - Behavioral Innovations was founded in 2000 and serves children ages 18 months to 10 years. - The organization says it partners with families, pediatric physicians and insurance providers to deliver evidence-based care. - The company also said full study methodology and underlying data are available upon request. - A white paper is available as Read the white paper.

Between the lines: - The timing suggests Behavioral Innovations is trying to position outcome measurement as a differentiator in a field where accountability is under more public pressure. - The emphasis on age 2 supports a familiar finding in autism care: earlier intervention can produce stronger gains. - The use of a standardized assessment makes the results easier to compare across patients and potentially across providers, though the study remains a company-published retrospective analysis. - CEO Ed Maher said the company aims to stay at the leading edge of the profession and take pride in improving its craft. - Maher also said the company wants families to see the magnitude of what is possible in their children’s progress.

What’s next: - Behavioral Innovations said interview opportunities are available with clinical leadership. - The company said the full methodology and underlying data can be shared upon request. - The release positions the provider to keep pushing for broader adoption of standardized outcomes reporting in ABA therapy.

The bottom line: - Behavioral Innovations is using a 1,141-child study to argue that ABA therapy progress can be measured, compared and publicly reported at scale.